Journal Watch · Cell Host & Microbe · 2026

Epigenetic phase variation in the gut microbiome enhances bacterial adaptation.

Thus, epigenetic modifications are used by gut bacteria to adapt to fluctuating environments.

Ni M, Junker K, Liu Y et al.Cell Host & Microbe3 min readPharma relevance 65/100

DOI: 10.1016/j.chom.2026.04.019PMID: 42161263Study type: genomics / omics study

TL;DR

Thus, epigenetic modifications are used by gut bacteria to adapt to fluctuating environments.

Key findings

  • Focusing on an Akkermansia muciniphila isolate, we find a specific ePV regulating mucC, a gene of unknown function but whose heterologous expression enhances bacterial tolerance to antibiotics via a bet-hedging strategy.
  • Thus, epigenetic modifications are used by gut bacteria to adapt to fluctuating environments.

What they did

Long-read metagenomics revealed genome-wide ePV mediated by structural variations of DNA methyltransferases. Analysis of public short-read metagenomic datasets further revealed a high prevalence of genome-wide ePVs in the human microbiome. Site-specific ePVs were identified and associated with antibiotics or probiotic engraftment.

Full abstract (original)

Background: The human microbiome continuously adapts to variations in diet and host physiology. Epigenetic phase variation (ePV) mediated by bacterial DNA methylation can generate phenotypic heterogeneity within clonal populations. ePVs have been characterized in human pathogens, but their roles in commensals remain unclear. Here, we cataloged ePVs in infant and adult gut microbiomes, revealing genome-wide and site-specific ePV in response to antibiotics and fecal microbiota transplantation.

What they did: Long-read metagenomics revealed genome-wide ePV mediated by structural variations of DNA methyltransferases. Analysis of public short-read metagenomic datasets further revealed a high prevalence of genome-wide ePVs in the human microbiome. Site-specific ePVs were identified and associated with antibiotics or probiotic engraftment.

Results & conclusions: Focusing on an Akkermansia muciniphila isolate, we find a specific ePV regulating mucC, a gene of unknown function but whose heterologous expression enhances bacterial tolerance to antibiotics via a bet-hedging strategy. Thus, epigenetic modifications are used by gut bacteria to adapt to fluctuating environments.

Abstract © the authors / Cell Host & Microbe (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1016/j.chom.2026.04.019 · PubMed 42161263.

Why it matters for pharma & biotech

  • Directly relevant to teams in microbiome therapeutics — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: microbiome therapeutics

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Cell Host & Microbe study find?

Thus, epigenetic modifications are used by gut bacteria to adapt to fluctuating environments.

What type of study is this?

It is a genomics / omics study, published in Cell Host & Microbe in 2026. Long-read metagenomics revealed genome-wide ePV mediated by structural variations of DNA methyltransferases.

Where can I read the original paper?

The original is at the publisher via DOI 10.1016/j.chom.2026.04.019. PubMed ID: 42161263. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Ni M, Junker K, Liu Y et al.. Epigenetic phase variation in the gut microbiome enhances bacterial adaptation.. Cell Host & Microbe (2026). DOI: 10.1016/j.chom.2026.04.019.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/epigenetic-phase-variation-in-the-gut-microbiome-enhances-bacterial-adap-604019/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides